Dubai Dubai Dubai is at the heart of our IMETA region. Explore career development opportunities in the UAE or our 170 locations around the globe.
EASi-KIDNEY™ Phase III trial for people with CKD EASi-KIDNEY™ Phase III trial for people with CKD Boehringer Ingelheim's Sandy Sommer on how treatment innovations in CKD can also improve care for connected conditions, including heart failure.
Advances in vectored vaccines for poultry Advances in vectored vaccines for poultry Vaccine design technologies have made huge advances in recent years. One of the newer categories of vaccine, vectored vaccines, is overcoming challenges that conventional vaccines do not meet.
Galym Zhunisbekov Galym Zhunisbekov Galym Zhunisbekov, a Regional Regulatory Affairs Manager in Eastern Europe, reflects on our philosophy and our impact on millions of lives.
New exchange platform with Harbin Research Institute New exchange platform with Harbin Research Institute Boehringer Ingelheim and Harbin Veterinary Research Institute set up ‘industry-academia-research’ exchange platform
Building Successful Partnerships in Animal Health Building Successful Partnerships in Animal Health Christoph Vetten, Head of Transactions Animal Health, shares his perspectives on how building successful collaborations can drive innovation.
The digital therapeutic solution halving hospitalization rates The digital therapeutic solution halving hospitalization rates Around 750,000 people live with chronic heart failure in Canada. The Medly program empowers patients with heart failure to manage their condition
LastMile – improving through digital LastMile – improving through digital LastMile initiative is an integrated, solutions-driven program seeking to make animal medical resources available in hard-to-reach areas in Africa.
FDA accepts new chronic kidney disease treatment application FDA accepts new chronic kidney disease treatment application FDA accepts new chronic kidney disease treatment application
Employees empower small dairy producers Employees empower small dairy producers Boehringer Ingelheim social intrapreneurship helps farmers improve animal welfare and the well-being of rural communities in Southern India.
Joint venture to fight Antimicrobial Resistance Joint venture to fight Antimicrobial Resistance Boehringer Ingelheim, Evotec and bioMérieux launch Aurobac, a joint venture to fight Antimicrobial Resistance
Their dogs are their world Their dogs are their world Corporate social responsibility in Brazil: Volunteer work and animal healthcare donations for homeless people and their pets.
TCs-28062019_TCoTF_Crowdsourcing_Terms_Conditions_5.0_FINAL.pdf TCs-28062019_TCoTF_Crowdsourcing_Terms_Conditions_5.0_FINAL.pdf